Late Breaking: Five Year Clinical and Echocardiographic Outcomes in Low-Risk Patients Undergoing Surgery in the PARTNER 3 Trial

Presenting Author(s)

• 

  Vinod H. Thourani, MD

  Marcus Chairman of Cardiovascular Surgery
  Piedmont Heart Institute and Piedmont Healthcare
  Atlanta, Georgia, United States

  Disclosure(s): Abbott Vascular: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Artivion: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); AtriCure: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Boston Scientific: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); dasi simulations: Advisory Board (Ongoing); Edwards Life Science: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Jenavalve: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)